Staff Members - Benha University
Impact of low-dose aspirin on coronary artery spasm as assessed by intracoronary acetylcholine provocation test in Korean patients
• 2016
Publication Information
Authors
Ji Young Park (MD)a,b, Seung-Woon Rha (MD, PHD)a,∗,
Kanhaiya L. Poddar (MD)a, Sureshkumar Ramasamy (MD, DM)a,c,
Kang-Yin Chen (MD, PHD)a,d, Yong-Jian Li (MD, PHD)a,e, Byoung Geol Choia,
Sung Kee Ryu (MD, PHD)b, Jae Woong Choi (MD, PHD)b,
Sang Hyun Par
Keywords
Not Available
Journal
Not Available
Publisher
Not Available
Volume
Not Available
Issue
Not Available
Pages
Not Available
publication.type
International
Paper Link
Not Available
Supplementary Materials
Not Available
Abstract
The patients were divided into two groups: the aspirin group taking LDA before ACh test (n = 221)
and the no aspirin group not taking aspirin (n = 2568). At baseline, the prevalence of old age,
diabetes mellitus, hypertension, and hyperlipidemia were higher in the aspirin group. During the
ACh test, the incidence of significant CAS, ischemic chest pain, as well as severe and multivessel
spasm was higher in the aspirin group. The response rate to lower ACh dose was higher in the
aspirin group. Multivariate analysis showed that the previous use of LDA was an independent
predictor of CAS (adjusted odds ratio, 1.6, 95% confidence interval, 1.0—2.3; p = 0.031). However,
it is likely that the association of LDA and CAS that we have observed is not causal but may be
hypothesis generating due to significant baseline differences. Further, male gender, old age,
lipid-lowering drugs, baseline spasm, and myocardial bridge were independent predictors of
CAS. LDA was more frequently associated with CAS and ischemic symptoms, as well as severe and
multivessel spasm, suggesting the patients who have received LDA would require more intensive
medical therapies and close follow up.
and the no aspirin group not taking aspirin (n = 2568). At baseline, the prevalence of old age,
diabetes mellitus, hypertension, and hyperlipidemia were higher in the aspirin group. During the
ACh test, the incidence of significant CAS, ischemic chest pain, as well as severe and multivessel
spasm was higher in the aspirin group. The response rate to lower ACh dose was higher in the
aspirin group. Multivariate analysis showed that the previous use of LDA was an independent
predictor of CAS (adjusted odds ratio, 1.6, 95% confidence interval, 1.0—2.3; p = 0.031). However,
it is likely that the association of LDA and CAS that we have observed is not causal but may be
hypothesis generating due to significant baseline differences. Further, male gender, old age,
lipid-lowering drugs, baseline spasm, and myocardial bridge were independent predictors of
CAS. LDA was more frequently associated with CAS and ischemic symptoms, as well as severe and
multivessel spasm, suggesting the patients who have received LDA would require more intensive
medical therapies and close follow up.